Vanasse, Alain <br/><br/>
Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients.  [electronic resource] 

 -  Diabetes & vascular disease research  Apr 2009 
 - 87-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1752-8984 
<br/><br/><label>Standard No.: </label>10.1177/1479164109336047  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Case-Control Studies<br/>Diabetes Mellitus--drug therapy<br/>Drug Prescriptions<br/>Heart Failure--chemically induced<br/>Hospitalization<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Logistic Models<br/>Myocardial Infarction--chemically induced<br/>Odds Ratio<br/>Quebec--epidemiology<br/>Registries<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Rosiglitazone<br/>Stroke--chemically induced<br/>Thiazolidinediones--adverse effects<br/>Treatment Outcome